Law360, New York (October 12, 2010) -- Teva Pharmaceuticals USA Inc. has lost its bid to force Sandoz Inc. and Momenta Pharmaceuticals Inc. to provide advance notice of their intent and ability to launch a generic version of Teva's multiple sclerosis drug Copaxone.
Judge Barbara S. Jones of the U.S. District Court for the Southern District of New York on Tuesday denied Teva's request for an order directing the generic-drug makers to provide...
Just the first section of the story. Anyone have the full text of the news story?